SCHEMBL30056597

SCHEMBL30056597

CC(Oc1ccc2c(-c3ccccc3Cl)cc(=O)oc2c1)C(=O)N1CCCC(C(=O)O)C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 1/20 0.56
▸ CYP3A4 P08684 2/20 0.53
▸ CYP2C9 P11712 2/20 0.53
▸ CYP2C19 P33261 2/20 0.53
▸ ALDH1A1 P00352 6/20 0.49
▸ HPGD P15428 6/20 0.49
▸ KDM4E B2RXH2 6/20 0.48
▸ KMT2A Q03164 5/20 0.48
▸ HTT P42858 3/20 0.48
▸ MAPT P10636 2/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ MEN1 O00255 2/20 0.45
▸ USP2 O75604 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ CA12 O43570 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ RECQL P46063 1/20 0.44
▸ AR P10275 1/20 0.42
▸ LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20839414 1.00 RAB9A (0.56) RAB9ACYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL30056756 1.00 RAB9A (0.56) RAB9ACYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL30055525 1.00 RAB9A (0.56) RAB9ACYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL20839410 1.00 RAB9A (0.56) RAB9ACYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL30056660 1.00 RAB9A (0.56) RAB9ACYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL20839473 1.00 RAB9A (0.56) RAB9ACYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL20839104 1.00 RAB9A (0.56) RAB9ACYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL20839399 0.95 CYP3A4 (0.54) RAB9ACYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL22431697 0.95 CYP3A4 (0.54) RAB9ACYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL30055449 0.95 CYP3A4 (0.54) RAB9ACYP3A4CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111386261-B Coumarin derivatives, process for their preparation and their use in the treatment of cancer 利德发现中心有限责任公司 2024-03-22 — — CN claimed
CN-111386261-B Coumarin derivatives, process for their preparation and their use in the treatment of cancer 利德发现中心有限责任公司 2024-03-22 — — CN disclosed
EP-4333822-A1 COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION Lead Discovery Center GmbH (DE) 2024-03-13 — — EP disclosed
WO-2022233782-A1 COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION LEAD DISCOVERY CENTER GMBH (DE) 2022-11-10 — — WO disclosed
Send feedback